Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FEBUXOSTAT vs FEDRATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FEBUXOSTAT vs FEDRATINIB: Safety Overview

Metric FEBUXOSTAT FEDRATINIB
Total FAERS Reports 5,843 1,404
Deaths Reported 404 203
Death Rate 6.9% 14.5%
Hospitalizations 1,755 294
Average Patient Age 66.7 yrs 71.1 yrs
% Female Patients 31.6% 48.7%
FDA Approval Date Dec 19, 2023 Aug 16, 2019
Manufacturer Novadoz Pharmaceuticals LLC Celgene Corporation
Route ORAL ORAL
Marketing Status Prescription Prescription